These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26391902)

  • 1. Investigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocket.
    Van Nguyen H; Nguyen HT; Le LT
    Eur Biophys J; 2016 Jan; 45(1):63-70. PubMed ID: 26391902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational investigation of drug-resistant mutant of M2 proton channel (S31N) against rimantadine.
    Karthick V; Ramanathan K
    Cell Biochem Biophys; 2014 Nov; 70(2):975-82. PubMed ID: 24807842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
    Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
    J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flu channel drug resistance: a tale of two sites.
    Pielak RM; Chou JJ
    Protein Cell; 2010 Mar; 1(3):246-58. PubMed ID: 21203971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence.
    Durrant MG; Eggett DL; Busath DD
    BMC Genet; 2015; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25953496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
    Gleed ML; Busath DD
    J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin].
    Kiselev OI; Mishin VP; Eroshkin VI; Kozeletskaia KN; Usova EV; Rudenko VI; Chupakhin ON
    Mol Biol (Mosk); 1994; 28(5):1009-13. PubMed ID: 7990823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations.
    Gu RX; Liu LA; Wang YH; Xu Q; Wei DQ
    J Phys Chem B; 2013 May; 117(20):6042-51. PubMed ID: 23594107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.